Stephen Liu, Chief of Hematology and Oncology at Georgetown University, shared on X:
“Dr. Ola Khorshid provides an overview of managing EGFR mutant NSCLC at EOS 2026 including how she navigates the first line combination space and resistance.”
You can also read:
Emirates Oncology Society and OncoDaily Announce Strategic Partnership
